What to expect when you take Potassium citrate and have Pain?

Do you take Potassium citrate and have Pain? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 16, 2018

463 reports have been studied.


Females aged 50 to 59 :

294 related reports were analyzed:

Most common symptoms:

Abdominal fullness prematurely after meals
  • 8.3% for females aged 50 (±5) who take Potassium citrate
Abdominal pain
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Abdominal pain upper
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Accidental overdose (therapeutic agent)
  • 13.04% for females aged 50 (±5) who take Potassium citrate
Acquired oesophageal web
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Acute kidney failure
  • 10.67% for females aged 50 (±5) who take Potassium citrate
Ageusia
  • 11.07% for females aged 50 (±5) who take Potassium citrate
Anaemia
  • 13.04% for females aged 50 (±5) who take Potassium citrate
Appetite - decreased
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Aseptic necrosis
  • 14.62% for females aged 50 (±5) who take Potassium citrate
Back pain
  • 18.58% for females aged 50 (±5) who take Potassium citrate
Bone disorder
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Breast cancer recurrent
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Bursitis
  • 5.93% for females aged 50 (±5) who take Potassium citrate
Cardiac failure congestive
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Carpal tunnel syndrome
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Cartilage injury
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Cataract
  • 8.7% for females aged 50 (±5) who take Potassium citrate
Cellulitis
  • 7.51% for females aged 50 (±5) who take Potassium citrate
Chest pain
  • 13.83% for females aged 50 (±5) who take Potassium citrate
Chest wall mass
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Chills
  • 14.62% for females aged 50 (±5) who take Potassium citrate
Chondromalacia
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Deformity
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Device related infection
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Diarrhea
  • 28.46% for females aged 50 (±5) who take Potassium citrate
Diverticulum
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Dizziness
  • 16.6% for females aged 50 (±5) who take Potassium citrate
Drug intolerance
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Dry mouth
  • 17.39% for females aged 50 (±5) who take Potassium citrate
Dyspnea
  • 15.02% for females aged 50 (±5) who take Potassium citrate
Ear pain
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Electrocardiogram abnormal
  • 7.91% for females aged 50 (±5) who take Potassium citrate
Emotional distress
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Eye infection
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Eye pain
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Facial bones fracture
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Fall
  • 13.44% for females aged 50 (±5) who take Potassium citrate
Fatigue
  • 15.42% for females aged 50 (±5) who take Potassium citrate
Femur fracture
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Fever
  • 26.88% for females aged 50 (±5) who take Potassium citrate
Fibromyalgia
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Flatulence
  • 9.49% for females aged 50 (±5) who take Potassium citrate
Food intolerance
  • 10.67% for females aged 50 (±5) who take Potassium citrate
Foot deformity
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Gastritis
  • 5.93% for females aged 50 (±5) who take Potassium citrate
Gastrointestinal inflammation
  • 11.07% for females aged 50 (±5) who take Potassium citrate
Genital herpes
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Glossitis
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Groin pain
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Haematemesis
  • 9.88% for females aged 50 (±5) who take Potassium citrate
Haemolytic anaemia
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Haemorrhoids
  • 8.7% for females aged 50 (±5) who take Potassium citrate
Hand fracture
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Headache
  • 15.42% for females aged 50 (±5) who take Potassium citrate
Heart palpitations
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Hepatic cyst
  • 8.3% for females aged 50 (±5) who take Potassium citrate
Hepatic enzyme increased
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Hiatal hernia
  • 11.07% for females aged 50 (±5) who take Potassium citrate
High blood cholesterol
  • 13.04% for females aged 50 (±5) who take Potassium citrate
High blood pressure
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Hip fracture
  • 10.67% for females aged 50 (±5) who take Potassium citrate
Hyperkeratosis
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Hypertonic bladder
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Hypoaesthesia
  • 13.83% for females aged 50 (±5) who take Potassium citrate
Hypomania
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Ilium fracture
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Incontinence
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Indigestion
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Infection
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Injury
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Insomnia
  • 13.04% for females aged 50 (±5) who take Potassium citrate
Intervertebral disc protrusion
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Irritable bowel syndrome
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Itching
  • 5.93% for females aged 50 (±5) who take Potassium citrate
Joint effusion
  • 15.81% for females aged 50 (±5) who take Potassium citrate
Joint injury
  • 10.67% for females aged 50 (±5) who take Potassium citrate
Joint pain
  • 17.39% for females aged 50 (±5) who take Potassium citrate
Lung infiltration
  • 13.04% for females aged 50 (±5) who take Potassium citrate
Lymph follicular hypertrophy
  • 7.51% for females aged 50 (±5) who take Potassium citrate
Major depression
  • 6.32% for females aged 50 (±5) who take Potassium citrate
Malaise
  • 5.53% for females aged 50 (±5) who take Potassium citrate
Melaena
  • 8.3% for females aged 50 (±5) who take Potassium citrate
Meniscus lesion
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Metastases to liver
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Metastases to lung
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Mitral valve incompetence
  • 8.3% for females aged 50 (±5) who take Potassium citrate
Mitral valve prolapse
  • 5.93% for females aged 50 (±5) who take Potassium citrate
Mouth ulcers
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Musculoskeletal pain
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Nausea
  • 30.43% for females aged 50 (±5) who take Potassium citrate
Nausea and vomiting
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Neck pain
  • 13.44% for females aged 50 (±5) who take Potassium citrate
Neuralgia
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Neuritis
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Nosebleed
  • 11.46% for females aged 50 (±5) who take Potassium citrate
Oedema peripheral
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Oral discomfort
  • 11.07% for females aged 50 (±5) who take Potassium citrate
Osteoarthritis
  • 16.21% for females aged 50 (±5) who take Potassium citrate
Osteomyelitis chronic
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Osteonecrosis of jaw
  • 17.39% for females aged 50 (±5) who take Potassium citrate
Pain in extremity
  • 16.6% for females aged 50 (±5) who take Potassium citrate
Pain in jaw
  • 15.02% for females aged 50 (±5) who take Potassium citrate
Protein - urine
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Pseudomonas infection
  • 10.28% for females aged 50 (±5) who take Potassium citrate
Pulmonary oedema
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Pyuria
  • 5.14% for females aged 50 (±5) who take Potassium citrate
Rash maculo-papular
  • 9.49% for females aged 50 (±5) who take Potassium citrate
Rashes
  • 20.55% for females aged 50 (±5) who take Potassium citrate
Renal tubular acidosis
  • 16.21% for females aged 50 (±5) who take Potassium citrate
Respiratory acidosis
  • 9.88% for females aged 50 (±5) who take Potassium citrate
Respiratory distress
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Salivary gland disorder
  • 5.53% for females aged 50 (±5) who take Potassium citrate
Scoliosis
  • 18.58% for females aged 50 (±5) who take Potassium citrate
Sinus headache
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Sjogren syndrome
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Sleep apnea syndrome
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Spinal column stenosis
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Spinal osteoarthritis
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Stomatitis
  • 6.72% for females aged 50 (±5) who take Potassium citrate
Stress and anxiety
  • 15.81% for females aged 50 (±5) who take Potassium citrate
Swallowing difficulty
  • 10.67% for females aged 50 (±5) who take Potassium citrate
Swallowing pain or burning
  • 8.3% for females aged 50 (±5) who take Potassium citrate
Synovial cyst
  • 12.65% for females aged 50 (±5) who take Potassium citrate
Tenosynovitis stenosans
  • 7.91% for females aged 50 (±5) who take Potassium citrate
The flu
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Tongue ulceration
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Tooth abscess
  • 12.25% for females aged 50 (±5) who take Potassium citrate
Tooth extraction
  • 11.86% for females aged 50 (±5) who take Potassium citrate
Urethral stenosis
  • 7.51% for females aged 50 (±5) who take Potassium citrate
Urinary retention
  • 9.09% for females aged 50 (±5) who take Potassium citrate
Urinary tract infection
  • 19.37% for females aged 50 (±5) who take Potassium citrate
Visual acuity reduced
  • 13.04% for females aged 50 (±5) who take Potassium citrate
Weakness
  • 11.46% for females aged 50 (±5) who take Potassium citrate
Weight decreased
  • 9.09% for females aged 50 (±5) who take Potassium citrate

Most common co-existing conditions:

Breast cancer
  • 17.07% for females aged 50 (±5) who take Potassium citrate and have pain
Constipation
  • 5.53% for females aged 50 (±5) who take Potassium citrate
Depression
  • 5.53% for females aged 50 (±5) who take Potassium citrate
High blood cholesterol
  • 6.32% for females aged 50 (±5) who take Potassium citrate
High blood pressure
  • 7.11% for females aged 50 (±5) who take Potassium citrate
Multiple sclerosis
  • 6.72% for females aged 50 (±5) who take Potassium citrate
Osteoporosis
  • 6.72% for females aged 50 (±5) who take Potassium citrate
Rheumatoid arthritis
  • 5.53% for females aged 50 (±5) who take Potassium citrate
back to top

Males aged 50 to 59 :

169 related reports were analyzed:

Most common symptoms:

Anaemia
  • 5.33% for males aged 50 (±5) who take Potassium citrate
Appetite - decreased
  • 7.69% for males aged 50 (±5) who take Potassium citrate
Blood glucose increased
  • 5.33% for males aged 50 (±5) who take Potassium citrate
Drug ineffective
  • 7.1% for males aged 50 (±5) who take Potassium citrate
Nausea
  • 7.1% for males aged 50 (±5) who take Potassium citrate
Nausea and vomiting
  • 5.92% for males aged 50 (±5) who take Potassium citrate
Weakness
  • 6.51% for males aged 50 (±5) who take Potassium citrate

Most common co-existing conditions:

Crohn's disease
  • 8.88% for males aged 50 (±5) who take Potassium citrate
Diabetes
  • 5.33% for males aged 50 (±5) who take Potassium citrate
Gout
  • 6.51% for males aged 50 (±5) who take Potassium citrate
High blood cholesterol
  • 14.2% for males aged 50 (±5) who take Potassium citrate
High blood pressure
  • 18.34% for males aged 50 (±5) who take Potassium citrate
Type 2 diabetes
  • 5.33% for males aged 50 (±5) who take Potassium citrate
back to top

Do you take Potassium citrate and have Pain:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

potassium citrate

Potassium citrate has active ingredients of potassium citrate. It is often used in kidney stones. (latest outcomes from Potassium citrate 2,403 users)

pain

Pain has been reported by people with rheumatoid arthritis, pain, multiple sclerosis, osteoporosis, birth control (latest reports from 598,543 Pain patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.